What is included in patient education for methemoglobinemia?

Updated: Dec 09, 2018
  • Author: Mary Denshaw-Burke, MD, FACP; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Patients with inherited methemoglobinemia should be counseled regarding the avoidance of toxins, chemicals, and certain drugs (eg, dapsone). Genetic counseling is important. Treatment of type II cases does not prevent or reverse CNS progression.

Patients with both congenital and acquired methemoglobinemia should receive instructions regarding avoidance of precipitating factors.

Patients who develop methemoglobinemia from the oxidant stress of pharmaceutical agents should be warned about other potent oxidant compounds. Patients who develop methemoglobinemia secondary to environmental exposure require a meticulous workup to prevent reexposure to the offending agent. All workplace or household members should be evaluated.

Patients receiving therapy for chronic methemoglobinemia should receive adequate information regarding the risks and benefits expected with treatment.

For patient education resources, see Anemia.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!